Sanofi (SNYNF)

Market Cap	113.29B
Revenue (ttm)	53.89B
Net Income (ttm)	10.69B
Shares Out	n/a
EPS (ttm)	8.67
PE Ratio	10.60
Forward PE	9.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	13,106
Open	94.12
Previous Close	91.53
Day's Range	94.12 - 94.12
52-Week Range	90.00 - 122.03
Beta	0.40
RSI	47.34
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR